Clinical Trials Browser

Phase 3 × Terminated × ruxolitinib × Clear all

NCT04551053 2025-10-02

To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

Phase 3 Terminated

177 enrolled 15 charts

Myeloproliferative Disorders, Primary Myelofibrosis

NCT04934670 2024-08-27

2002

Phase 3 Terminated

12 enrolled 12 charts

Pathologic Complete Response, Lymphoma, Follicular

NCT02117479 2019-03-26

Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)

Phase 3 Terminated

321 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02119663 2018-02-13

A Study of Ruxolitinib in Pancreatic Cancer Patients

Phase 3 Terminated

86 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms